ArticleClinical parkinsonism & related disorders2025
Opicapone improves end-of-dose neuropsychiatric fluctuations in patients with Parkinson's disease.
Roberta De Fiores et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it